Euro-Celtique

Euro-Celtique is a Luxembourg-based pharmaceutical company that functions as a primary intellectual property and holding entity within the Mundipharma Group, the international network of companies owned by the Sackler family. The company is most recognized for holding the global patents and trademarks for blockbuster pain management therapies, including the controlled-release opioid OxyContin. In addition to its dominant position in analgesics, Euro-Celtique manages a diverse portfolio of assets in respiratory medicine, oncology, and consumer healthcare. It operates as a strategic hub for licensing, asset management, and corporate structuring for the group's operations outside of the United States. The company has been central to the legal and corporate history of the Sackler family's pharmaceutical interests, particularly regarding the global commercialization of opioid products.